Sheets Smith Wealth Management Pfizer Inc Transaction History

Sheets Smith Wealth Management

$807 Million
Q3 2024

A detailed history of Sheets Smith Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Sheets Smith Wealth Management holds 53,937 shares of PFE stock, worth $1.42 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

53,937

Previous 56,833 5.1%

Holding current value

$1.42 Million

Previous $1.59 Million 1.89%

% of portfolio

0.19%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $80,219 - $90,905	-2,896 Reduced 5.1%	53,937 $1.56 Million
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $242,900 - $284,633	-9,616 Reduced 14.47%	56,833 $1.59 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $627,392 - $720,447	24,233 Added 57.4%	66,449 $1.84 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $233,236 - $302,948	-8,926 Reduced 17.45%	42,216 $1.22 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $34,432 - $40,248	-1,073 Reduced 2.05%	51,142 $1.7 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $8,090 - $9,360	224 Added 0.43%	52,215 $1.92 Million
Q1 2023 May 26, 2023	BUY	$39.39 - $51.28 $2.05 Million - $2.66 Million	51,950 Added 126707.32%	51,991 $2.12 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $2.07 Million - $2.7 Million	-52,579 Reduced 99.92%	41 $1,000
Q4 2022 Mar 08, 2023	SELL	$41.75 - $54.5 $250 - $327	-6 Reduced 0.01%	52,620 $2.7 Million
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $35,051 - $42,789	-801 Reduced 1.5%	52,626 $2.3 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $97,433 - $115,525	-2,094 Reduced 3.77%	53,427 $2.8 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $193,934 - $240,308	-4,239 Reduced 7.09%	55,521 $2.87 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $212,467 - $314,947	5,142 Added 9.41%	59,760 $3.53 Million
Q3 2021 Oct 15, 2021	BUY	$39.25 - $50.42 $225,687 - $289,915	5,750 Added 11.77%	54,618 $2.35 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $28,476 - $32,259	793 Added 1.65%	48,868 $1.91 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $19,591 - $22,095	585 Added 1.23%	48,075 $1.74 Million
Q4 2020 Jan 13, 2021	SELL	$33.47 - $42.56 $10,911 - $13,874	-326 Reduced 0.68%	47,490 $1.75 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $91,821 - $107,727	2,892 Added 6.44%	47,816 $1.76 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $72,769 - $88,280	2,416 Added 5.68%	44,924 $1.47 Million
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $79,143 - $113,079	-2,928 Reduced 6.44%	42,508 $1.39 Million
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $84,176 - $95,529	-2,557 Reduced 5.33%	45,436 $1.78 Million
Q3 2019 Oct 28, 2019	BUY	$32.49 - $42.13 $8,837 - $11,459	272 Added 0.57%	47,993 $1.72 Million
Q2 2019 Jul 12, 2019	BUY	$36.98 - $41.52 $8,061 - $9,051	218 Added 0.46%	47,721 $2.07 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $9,075 - $9,970	-242 Reduced 0.51%	47,503 $2.02 Million
Q4 2018 Jan 11, 2019	SELL	$38.47 - $43.86 $12,695 - $14,473	-330 Reduced 0.69%	47,745 $2.08 Million
Q3 2018 Oct 15, 2018	BUY	$34.47 - $41.81 $7,686 - $9,323	223 Added 0.47%	48,075 $2.12 Million
Q2 2018 Jul 26, 2018	SELL	$32.98 - $35.16 $7,222 - $7,700	-219 Reduced 0.46%	47,852 $1.74 Million
Q1 2018 Apr 09, 2018	BUY	$31.91 - $37.02 $7,530 - $8,736	236 Added 0.49%	48,071 $1.71 Million
Q4 2017 Jan 12, 2018	BUY	$33.26 - $35.29 $13,137 - $13,939	395 Added 0.83%	47,835 $1.73 Million
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $1.47 Million - $1.62 Million	47,440	47,440 $1.69 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Pfizer Inc Transaction History